相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Airborne or Droplet Precautions for Health Workers Treating Coronavirus Disease 2019?
Prateek Bahl et al.
JOURNAL OF INFECTIOUS DISEASES (2022)
Should children be vaccinated against COVID-19?
Petra Zimmermann et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2022)
Assessment of hand hygiene strategies on skin barrier function during COVID-19 pandemic: A randomized clinical trial
Trinidad Montero-Vilchez et al.
CONTACT DERMATITIS (2022)
Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study
Vivek Naranbhai et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older Adults
Mark A. Brockman et al.
JOURNAL OF INFECTIOUS DISEASES (2022)
Angioimmunoblastic T-cell lymphoma: treatment strategies and prognostic factors from a retrospective multicenter study in China
Chen Zhang et al.
LEUKEMIA & LYMPHOMA (2022)
Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection
Ariel Israel et al.
VACCINES (2022)
A randomized controlled clinical trial on efficacy and safety of anakinra in patients with severe COVID-19
Amir Behnam Kharazmi et al.
IMMUNITY INFLAMMATION AND DISEASE (2022)
COVID-19 vaccine use in immunocompromised patients: A commentary on evidence and recommendations
Kristine Duly et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2022)
Ivermectin for the Treatment of Coronavirus Disease 2019: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Yuani M. Roman et al.
CLINICAL INFECTIOUS DISEASES (2022)
Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate Coronavirus Disease 2019 (COVID-19): A Real-World Experience
John Paul Verderese et al.
CLINICAL INFECTIOUS DISEASES (2022)
Decline of antibody titres 3 months after two doses of BNT162b2 in non-immunocompromised adults
Alejo Erice et al.
CLINICAL MICROBIOLOGY AND INFECTION (2022)
Letter to the Editor: Autoimmune hepatitis after COVID-19 vaccination: A rare adverse effect?
Panagiota Palla et al.
HEPATOLOGY (2022)
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19
Sebastian Havervall et al.
JOURNAL OF INTERNAL MEDICINE (2022)
Immune-mediated hepatitis with the Moderna vaccine, no longer a coincidence but confirmed
Gloria Shwe Zin Tun et al.
JOURNAL OF HEPATOLOGY (2022)
Mutations in TP53 or DNA damage repair genes define poor prognostic subgroups in primary prostate cancer
Cathleen Nientiedt et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2022)
Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19
Emily C. Somers et al.
CLINICAL INFECTIOUS DISEASES (2021)
Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care
Susan A. Olender et al.
CLINICAL INFECTIOUS DISEASES (2021)
Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review
A. Cortegiani et al.
PULMONOLOGY (2021)
Convalescent plasma is a clutch at straws in COVID-19 management! A systematic review and meta-analysis
Soumya Sarkar et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Dexamethasone in Hospitalized Patients with Covid-19
Peter Horby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Consequences of the COVID-19 Pandemic: Reduced Hemoglobin A1c Diabetes Monitoring
Maren S. Fragala et al.
POPULATION HEALTH MANAGEMENT (2021)
Repurposing Colchicine in Treating Patients with COVID-19: A Systematic Review and Meta-Analysis
Chi-Hone Lien et al.
LIFE-BASEL (2021)
Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study
Matthias B. Moor et al.
LANCET RHEUMATOLOGY (2021)
Ivermectin and mortality in patients with COVID-19: A systematic review, meta-analysis, and meta-regression of randomized controlled trials
Ahmad Fariz Malvi Zamzam Zein et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2021)
COVID-19 risk stratification algorithms based on sTREM-1 and IL-6 in emergency department
Mathias Van Singer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia A Randomized Clinical Trial
Olivier Hermine et al.
JAMA INTERNAL MEDICINE (2021)
Case Report: Home-based Management of Severe COVID-19 with Low-dose Tofacitinib
Ashish Sharma et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2021)
The Role of Masks in Mitigating the SARS-CoV-2 Pandemic: Another Piece of the Puzzle
Christine Laine et al.
ANNALS OF INTERNAL MEDICINE (2021)
Of Masks and Methods
Thomas R. Frieden et al.
ANNALS OF INTERNAL MEDICINE (2021)
Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers A Randomized Controlled Trial
Henning Bundgaard et al.
ANNALS OF INTERNAL MEDICINE (2021)
Anti-inflammatory therapy for COVID-19 infection: the case for colchicine
Aaron Z. Reyes et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Assessing mandatory stay-at-home and business closure effects on the spread of COVID-19
Eran Bendavid et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)
A systematic review of experimental evidence for antiviral effects of ivermectin and an in silico analysis of ivermectin's possible mode of action against SARS-CoV-2
Robert T. Kinobe et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2021)
Impact of colchicine on mortality in patients with COVID-19: A meta-analysis
Dimitrios A. Vrachatis et al.
HELLENIC JOURNAL OF CARDIOLOGY (2021)
Molecular docking identification for the efficacy of some zinc complexes with chloroquine and hydroxychloroquine against main protease of COVID-19
R. K. Hussein et al.
JOURNAL OF MOLECULAR STRUCTURE (2021)
COVID-19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology
Giuseppe Rosano et al.
EUROPEAN JOURNAL OF HEART FAILURE (2021)
Environment-lockdown, air pollution and related diseases: could we learn something and make it last?
Marija Jevtic et al.
EUROPEAN JOURNAL OF PUBLIC HEALTH (2021)
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
R. Libster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
A. C. Kalil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
Carlos Salama et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Peter Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial
Xavier Mariette et al.
LANCET RESPIRATORY MEDICINE (2021)
Meta-analysis of the Effect of Colchicine on Mortality and Mechanical Ventilation in COVID-19
Husam M. Salah et al.
AMERICAN JOURNAL OF CARDIOLOGY (2021)
Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity against SARS-CoV-2
Wendy P. Painter et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Implementing digital passports for SARS-CoV-2 immunization in Canada
Kumanan Wilson et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2021)
SARS-CoV-2 re-infection risk in Austria
Stefan Pilz et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)
SARS-CoV-2 re-infection rate in Iranian COVID-19 cases within one-year follow-up
Mostafa Salehi-Vaziri et al.
MICROBIAL PATHOGENESIS (2021)
Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19
Mohd Imran et al.
MOLECULES (2021)
COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: A multicenter interventional study
Sondas Alsharidah et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Monoclonal Antibodies for COVID-19
Elizabeth C. Lloyd et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19
Courtney Temple et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19
D. M. Weinreich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab
Anil Gupta et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study
Giorgio Bozzi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Diagnosis and Acute Management of COVID-19 and Multisystem Inflammatory Syndrome in Children
Teresa B. Kortz et al.
PEDIATRIC EMERGENCY CARE (2021)
Efficacy and safety of ivermectin for the treatment of COVID-19: a systematic review and meta-analysis
J. Deng et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2021)
Dexamethasone for treating SARS-CoV-2 infection: a systematic review and meta-analysis
Lirane Elize Defante Ferreto et al.
SAO PAULO MEDICAL JOURNAL (2021)
Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma
For Yue Tso et al.
PLOS ONE (2021)
Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19
Fasihul A. Khan et al.
THORAX (2021)
Methylprednisolone in adults hospitalized with COVID-19 pneumonia An open-label randomized trial (GLUCOCOVID)
Luis Corral-Gudino et al.
WIENER KLINISCHE WOCHENSCHRIFT (2021)
Function Is More Reliable Than Quantity to Follow Up the Humoral Response to the Receptor-Binding Domain of SARS-CoV-2-Spike Protein after Natural Infection or COVID-19 Vaccination
Carlos A. Sariol et al.
VIRUSES-BASEL (2021)
SARS-CoV-2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro (Publication with Expression of Concern. See vol. 14, 2022)
Hui Jiang et al.
VIRUSES-BASEL (2021)
Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia
Andre Santa Cruz et al.
FRONTIERS IN IMMUNOLOGY (2021)
Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals
Kenji Maeda et al.
SCIENTIFIC REPORTS (2021)
Correlation of mutational landscape and survival outcome of peripheral T-cell lymphomas
Yingying Ye et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2021)
Covid-19: Do vaccines work against omicron-and other questions answered
Elisabeth Mahase
BMJ-BRITISH MEDICAL JOURNAL (2021)
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
Pierre Kory et al.
AMERICAN JOURNAL OF THERAPEUTICS (2021)
Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia
Mayte Sanchez van Kammen et al.
JAMA NEUROLOGY (2021)
Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis
Qiao Liu et al.
INFECTIOUS DISEASES OF POVERTY (2021)
Genetic polymorphisms as multi-biomarkers in severe acute respiratory syndrome (SARS) by coronavirus infection: A systematic review of candidate gene association studies
Ana Caroline Melo dos Santos et al.
INFECTION GENETICS AND EVOLUTION (2021)
The Effect of Anakinra in Hospitalized Patients with COVID-19: An Updated Systematic Review and Meta-Analysis
Konstantinos G. Kyriakoulis et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine
Dimitrios A. Vrachatis et al.
JOURNAL OF CLINICAL MEDICINE (2021)
The Spectrum of Manifestations of Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV2) Infection in Children: What We Can Learn From Multisystem Inflammatory Syndrome in Children (MIS-C)
Salvatore Panaro et al.
FRONTIERS IN MEDICINE (2021)
Impact of the Addition of Baricitinib to Standard of Care Including Tocilizumab and Corticosteroids on Mortality and Safety in Severe COVID-19
Mar Masia et al.
FRONTIERS IN MEDICINE (2021)
Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report
Serge Goldman et al.
FRONTIERS IN MEDICINE (2021)
The Effectiveness of Convalescent Plasma for the Treatment of Novel Corona Virus Disease 2019: A Systematic Review and Meta-Analysis
Huiling Cao et al.
FRONTIERS IN MEDICINE (2021)
Efficacy of COVID-19 Treatments: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
Chenyang Zhang et al.
FRONTIERS IN PUBLIC HEALTH (2021)
Comorbidities' potential impacts on severe and non-severe patients with COVID-19 A systematic review and meta-analysis
Sixiang Cheng et al.
MEDICINE (2021)
Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types
Minghui Li et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
A pragmatic approach to COVID-19 vaccine passport
Ahmed Sharif et al.
BMJ GLOBAL HEALTH (2021)
Vaccine Passport Certification - Policy and Ethical Considerations
Mark A. Hall et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Predictors of Mortality in Critically Ill COVID-19 Patients Demanding High Oxygen Flow: A Thin Line between Inflammation, Cytokine Storm, and Coagulopathy
Viseslav Popadic et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)
Efficacy and safety of colchicine in COVID-19: a meta-analysis of randomised controlled trials
Kedar Gautambhai Mehta et al.
RMD OPEN (2021)
Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis
Evdoxia Kyriazopoulou et al.
LANCET RHEUMATOLOGY (2021)
The association between the use of ivermectin and mortality in patients with COVID-19: a meta-analysis
Chia Siang Kow et al.
PHARMACOLOGICAL REPORTS (2021)
Evaluation of potential COVID-19 recurrence in patients with late repeat positive SARS-CoV-2 testing
Ithan D. Peltan et al.
PLOS ONE (2021)
Long-term prognosis following hospitalization for acute myocarditis - a matched nationwide cohort study
Muzhda Ghanizada et al.
SCANDINAVIAN CARDIOVASCULAR JOURNAL (2021)
Brief report: Production of anti-SARS-CoV-2 hyperimmune globulin from convalescent plasma
Peter Vandeberg et al.
TRANSFUSION (2021)
Colchicine for the treatment of COVID-19 patients: efficacy, safety, and model informed dosage regimens
Eleni Karatza et al.
XENOBIOTICA (2021)
Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma
Harini Natarajan et al.
MBIO (2021)
Prophylaxis against covid-19: living systematic review and network meta-analysis
Jessica J. Bartoszko et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Covid-19 vaccine passports: access, equity, and ethics
Tasnime Osama et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Impact of COVID-19 on Outpatient Antimicrobial Prescribing Patterns in New York City
Monica Douglas et al.
INFECTIOUS DISEASES IN CLINICAL PRACTICE (2021)
Efficacy and safety of current medications for treating severe and non-severe COVID-19 patients: an updated network meta-analysis of randomized placebo-controlled trials
Qinglin Cheng et al.
Aging-US (2021)
Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines
Andrew Bryant et al.
AMERICAN JOURNAL OF THERAPEUTICS (2021)
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept
Nathalie Chavarot et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
Estimating age-specific COVID-19 fatality risk and time to death by comparing population diagnosis and death patterns: Australian data
Ian C. Marschner
BMC MEDICAL RESEARCH METHODOLOGY (2021)
Convalescent plasma for COVID-19: a meta-analysis, trial sequential analysis, and meta-regression
Timothy A. C. Snow et al.
BRITISH JOURNAL OF ANAESTHESIA (2021)
An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies
Yafei Liu et al.
CELL (2021)
Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients
Jeff Slezak et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
How trustworthy guidelines can impact outcomes
Bram Rochwerg et al.
CURRENT OPINION IN CRITICAL CARE (2021)
Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin
Guilherme Dias de Melo et al.
EMBO MOLECULAR MEDICINE (2021)
CONVALESCENT plasma for COVID-19: A meta-analysis of clinical trials and real-world evidence
Chiraphat Kloypan et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)
Low risk of reinfections and relation with serological response after recovery from the first wave of COVID-19
Maddalena Peghin et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2021)
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 AMeta-analysis
Manu Shankar-Hari et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
IL-6 Receptor Antagonist Therapy for Patients Hospitalized for COVID-19 Who, When, and How?
Michael A. Matthay et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Increase in Outpatient Ivermectin Dispensing in the US During the COVID-19 Pandemic: A Cross-Sectional Analysis
Jennifer N. Lind et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2021)
Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases
Paul J. Thuluvath et al.
JOURNAL OF HEPATOLOGY (2021)
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans
Jackson S. Turner et al.
NATURE (2021)
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
Evdoxia Kyriazopoulou et al.
NATURE MEDICINE (2021)
Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia
Patricia O. Guimaraes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19
M. P. O'Brien et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Early Convalescent Plasma for High-Risk Outpatients with Covid-19
Frederick K. Korley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
The Role of Subcutaneous Depot Medroxyprogesterone Acetate in Equitable Contraceptive Care A Lesson From the Coronavirus Disease 2019 (COVID-19) Pandemic
Audrey M. Burlando et al.
OBSTETRICS AND GYNECOLOGY (2021)
Development and Validation of a Multivariable Predictive Model for Mortality of COVID-19 Patients Demanding High Oxygen Flow at Admission to ICU: AIDA Score
Marija Zdravkovic et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)
Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism
Martine Policard et al.
VIRUS RESEARCH (2021)
Hydroxychloroquine and mortality in COVID-19 patients: a systematic review and a meta-analysis of observational studies and randomized controlled trials
Augusto Di Castelnuovo et al.
PATHOGENS AND GLOBAL HEALTH (2021)
Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial
Jurjan Aman et al.
LANCET RESPIRATORY MEDICINE (2021)
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection
Floriane Gallais et al.
EBIOMEDICINE (2021)
Poor Neutralizing Antibody Responses in 132 Patients with CLL, NHL and HL after Vaccination against SARS-CoV-2: A Prospective Study
Evangelos Terpos et al.
CANCERS (2021)
Antibody Responses to Natural SARS-CoV-2 Infection or after COVID-19 Vaccination
Haya Altawalah
VACCINES (2021)
Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies
Charles F. Schuler et al.
MICROBIOLOGY SPECTRUM (2021)
Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence
Stephen A. Klassen et al.
FRONTIERS IN MEDICINE (2021)
被撤回的出版物: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial (Publication with Expression of Concern. See vol. 8, 2022) (Retracted article. See vol. 9, 2022)
John McCoy et al.
FRONTIERS IN MEDICINE (2021)
Safety and Efficacy of Convalescent Plasma in COVID-19: An Overview of Systematic Reviews
Massimo Franchini et al.
DIAGNOSTICS (2021)
Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab's Place in COVID-19 Pneumonia
Timothee Klopfenstein et al.
INFECTIOUS DISEASES AND THERAPY (2021)
Differential p53-Mediated Cellular Responses to DNA-Damaging Therapeutic Agents
Lindsey Carlsen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Vaccine-Associated Thrombocytopenia and Thrombosis: Venous Endotheliopathy Leading to Venous Combined Micro-Macrothrombosis
Jae C. Chang et al.
MEDICINA-LITHUANIA (2021)
Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study
Paul Naaber et al.
LANCET REGIONAL HEALTH-EUROPE (2021)
A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies
Gabriela Athziri Sanchez-Zuno et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2021)
Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients
Matthieu Million et al.
REVIEWS IN CARDIOVASCULAR MEDICINE (2021)
Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial
Shaukat Ali et al.
ECLINICALMEDICINE (2021)
Long-term antibody-response monitoring following primary exposure to SARS-COV-2 and afterward mRNA COVID-19 vaccination: A case report
Bela Balint et al.
VOJNOSANITETSKI PREGLED (2021)
Does COVID-19 Vaccination Warrant the Classical Principle ofelein i mi vlaptin?
Michael Doulberis et al.
MEDICINA-LITHUANIA (2021)
Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
Flavio A. Cadegiani et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2021)
Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19
A. D. Santin et al.
NEW MICROBES AND NEW INFECTIONS (2021)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
On the use of corticosteroids for 2019-nCoV pneumonia
Lianhan Shang et al.
LANCET (2020)
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Clark D. Russell et al.
LANCET (2020)
COVID-19: combining antiviral and anti-inflammatory treatments
Justin Stebbing et al.
LANCET INFECTIOUS DISEASES (2020)
Risks of N95 Face Mask Use in Subjects With COPD
Sun Young Kyung et al.
RESPIRATORY CARE (2020)
Of chloroquine and COVID-19
Franck Touret et al.
ANTIVIRAL RESEARCH (2020)
Imatinib might constitute a treatment option for lung involvement in COVID-19
David Bernal-Bello et al.
AUTOIMMUNITY REVIEWS (2020)
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
Paola Toniati et al.
AUTOIMMUNITY REVIEWS (2020)
Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: Case series
Lerzan Dogan et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
RNF168-Mediated Ubiquitin Signaling Inhibits the Viability of BRCA1-Null Cancers
John J. Krais et al.
CANCER RESEARCH (2020)
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Xueting Yao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
Wei-jie Guan et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Colchicine's effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: results from a pilot randomized controlled trial
Andrew P. Demidowich et al.
INTERNATIONAL JOURNAL OF OBESITY (2020)
Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19
Tobias Herold et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
Fabrizio Cantini et al.
JOURNAL OF INFECTION (2020)
Updated diagnosis, treatment and prevention of COVID-19 in children: experts' consensus statement (condensed version of the second edition)
Kun-Ling Shen et al.
WORLD JOURNAL OF PEDIATRICS (2020)
A human monoclonal antibody blocking SARS-CoV-2 infection
Chunyan Wang et al.
NATURE COMMUNICATIONS (2020)
Face masks for the public during the covid-19 crisis
Trisha Greenhalgh et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Covid-19: Important potential side effects of wearing face masks that we should bear in mind
Antonio Ivan Lazzarino et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Covid-19: FDA approves use of convalescent plasma to treat critically ill patients
Janice Hopkins Tanne
BMJ-BRITISH MEDICAL JOURNAL (2020)
Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
Mandeep R Mehra et al.
LANCET (2020)
Hyperinflammatory shock in children during COVID-19 pandemic
Shelley Riphagen et al.
LANCET (2020)
Baricitinib for COVID-19: a suitable treatment?
Ennio G. Favalli et al.
LANCET INFECTIOUS DISEASES (2020)
Coronavirus disease 2019 (COVID-19): A literature review
Harapan Harapan et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2020)
Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19
Richard T. Eastman et al.
ACS CENTRAL SCIENCE (2020)
Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
Ruklanthi de Alwis et al.
EBIOMEDICINE (2020)
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
Jia Liu et al.
CELL DISCOVERY (2020)
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Jason D. Goldman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Children with Covid-19 in Pediatric Emergency Departments in Italy
Niccolo Parri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
SARS-CoV-2 Infection in Children
Xiaoxia Lu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Molecular immune pathogenesis and diagnosis of COVID-19
Xiaowei Li et al.
JOURNAL OF PHARMACEUTICAL ANALYSIS (2020)
Colchicine as a possible therapeutic option in COVID-19 infection
Rafael Parra-Medina et al.
CLINICAL RHEUMATOLOGY (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
Topical recombinant human acidic fibroblast growth factor: An effective therapeutic agent for facemask wearing-induced pressure sores
Pan Luo et al.
DERMATOLOGIC THERAPY (2020)
Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID-19: A Case Series
Iris Navarro-Millan et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Pharmacological and non-pharmacological efforts at prevention, mitigation, and treatment for COVID-19
Mohammed M. Alvi et al.
JOURNAL OF DRUG TARGETING (2020)
Changes in the Number of US Patients With Newly Identified Cancer Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic
Harvey W. Kaufman et al.
JAMA NETWORK OPEN (2020)
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019 The GRECCO-19 Randomized Clinical Trial
Spyridon G. Deftereos et al.
JAMA NETWORK OPEN (2020)
Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study
Fabrizio Cantini et al.
JOURNAL OF INFECTION (2020)
Rapid Systematic Review: The Impact of Social Isolation and Loneliness on the Mental Health of Children and Adolescents in the Context of COVID-19
Maria Elizabeth Loades et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2020)
Women are most affected by pandemics - lessons from past outbreaks
Clare Wenham et al.
NATURE (2020)
Focus shifts to antibody cocktails for COVID-19 cytokine storm
Charlotte Harrison
NATURE BIOTECHNOLOGY (2020)
The impact of the COVID-19 pandemic on suicide rates
Leo Sher
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2020)
Charities that fund research face deep revenue declines
Eli Cahan
SCIENCE (2020)
Should governments continue lockdown to slow the spread of covid-19?
Edward R. Melnick et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis
Jonathan A. C. Sterne et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 A Randomized Clinical Trial
Christoph D. Spinner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
An inflammatory cytokine signature predicts COVID-19 severity and survival
Diane Marie Del Valle et al.
NATURE MEDICINE (2020)
Serious Ivermectin Toxicity and Human ABCB1 Nonsense Mutations
Eloise Baudou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Edward E. Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
John H. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Negative impacts of COVID-19 lockdown on mental health service access and follow-up adherence for immigrants and individuals in socio-economic difficulties
M. Aragona et al.
PUBLIC HEALTH (2020)
Dexamethasone to combat cytokine storm in COVID-19: Clinical trials and preliminary evidence
Khan Sharun et al.
INTERNATIONAL JOURNAL OF SURGERY (2020)
Therapeutic potential of ivermectin as add on treatment in COVID 19: A systematic review and meta-analysis
Biswa Mohan Padhy et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2020)
Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy
Sahar Balagholi et al.
TRANSFUSION AND APHERESIS SCIENCE (2020)
Rapid and complete inactivation of SARS-CoV-2 by ultraviolet-C irradiation
Nadia Storm et al.
SCIENTIFIC REPORTS (2020)
Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study
Emma J. Kooistra et al.
CRITICAL CARE (2020)
Age-specific mortality and immunity patterns of SARS-CoV-2
Megan O'Driscoll et al.
NATURE (2020)
Clinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real world
M. Million et al.
NEW MICROBES AND NEW INFECTIONS (2020)
Drug repurposing and cytokine management in response to COVID-19: A review
Luana Heimfarth et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
COVID-19 and multisystem inflammatory syndrome in children and adolescents
Li Jiang et al.
LANCET INFECTIOUS DISEASES (2020)
Anakinra for severe forms of COVID-19: a cohort study
Thomas Huet et al.
LANCET RHEUMATOLOGY (2020)
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
Giulio Cavalli et al.
LANCET RHEUMATOLOGY (2020)
Macrophage activation syndrome and COVID-19
Ryo Otsuka et al.
INFLAMMATION AND REGENERATION (2020)
Plasma exchange in critically ill COVID-19 patients
Christian Morath et al.
CRITICAL CARE (2020)
Adverse events during oral colchicine use: a systematic review and meta-analysis of randomised controlled trials
Sarah Stewart et al.
ARTHRITIS RESEARCH & THERAPY (2020)
How COVID-19 induces cytokine storm with high mortality
Shintaro Hojyo et al.
INFLAMMATION AND REGENERATION (2020)
Update on the diagnosis and management of COVID-19 in pediatric patients
Ana Paula de Carvalho Panzeri Carlotti et al.
CLINICS (2020)
Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study
Noa Biran et al.
LANCET RHEUMATOLOGY (2020)
Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment
Josef S. Smolen et al.
JOURNAL OF RHEUMATOLOGY (2019)
Antibody-Dependent Cellular Phagocytosis in Antiviral Immune Responses
Matthew Zirui Tay et al.
FRONTIERS IN IMMUNOLOGY (2019)
Hydroxychloroquine: balancing the need to maintain therapeutic levels with ocular safety: an update
Nada Abdulaziz et al.
CURRENT OPINION IN RHEUMATOLOGY (2018)
TP53 mutations in peripheral mature T and NK cell lymphomas: a whole-exome sequencing study with correlation to p53 expression
Hui-Shan Huang et al.
HUMAN PATHOLOGY (2018)
Mitochondria, Oxidative Stress and Innate Immunity
Yuxin Chen et al.
FRONTIERS IN PHYSIOLOGY (2018)
Interleukin-1 function and role in rheumatic disease
Georg Schett et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Hydroxychloroquine augments early virological response to pegylated interferon plus ribavirin in genotype-4 chronic hepatitis C patients
Gouda Kamel Helal et al.
JOURNAL OF MEDICAL VIROLOGY (2016)
Targeting the RB-E2F pathway in breast cancer
J. Johnson et al.
ONCOGENE (2016)
The IL-1 cytokine family and its role in inflammation and fibrosis in the lung
L. A. Borthwick
SEMINARS IN IMMUNOPATHOLOGY (2016)
The enigma of the clandestine association between chloroquine and HIV-1 infection
A. Chauhan et al.
HIV MEDICINE (2015)
Long-Term T-Cell-Mediated Immunologic Memory to Hepatitis B Vaccine in Young Adults Following Neonatal Vaccination
Hiva Saffar et al.
HEPATITIS MONTHLY (2014)
Critical Role for the NLRP3 Inflammasome during Acute Lung Injury
Jamison J. Grailer et al.
JOURNAL OF IMMUNOLOGY (2014)
Coronavirus virulence genes with main focus on SARS-CoV envelope gene
Marta L. De Diego et al.
VIRUS RESEARCH (2014)
Technical Advance: Inhibition of neutrophil chemotaxis by colchicine is modulated through viscoelastic properties of subcellular compartments
Stephan Paschke et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
CD4 T-Cell Memory Responses to Viral Infections of Humans Show Pronounced Immunodominance Independent of Duration or Viral Persistence
Lichen Jing et al.
JOURNAL OF VIROLOGY (2013)
Cytokines in Sepsis: Potent Immunoregulators and Potential Therapeutic Targets-An Updated View
Wibke Schulte et al.
MEDIATORS OF INFLAMMATION (2013)
Hydroxychloroquine: From Malaria to Autoimmunity
Ilan Ben-Zvi et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2012)
Losing life and livelihood: A systematic review and meta-analysis of unemployment and all-cause mortality
David J. Roelfs et al.
SOCIAL SCIENCE & MEDICINE (2011)
Colchicine poisoning: the dark side of an ancient drug
Yaron Finkelstein et al.
CLINICAL TOXICOLOGY (2010)
New aspects of Helicobacter pylori infection involvement in gastric oncogenesis
Jannis Kountouras et al.
JOURNAL OF SURGICAL RESEARCH (2008)
Nonpharmaceutical interventions implemented by US cities during the 1918-1919 influenza pandemic
Howard Markel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
The antiviral effect of interferon-beta against SARS-coronavirus is not mediated by MxA protein
M Spiegel et al.
JOURNAL OF CLINICAL VIROLOGY (2004)